Results 11 to 20 of about 6,360 (195)

Whitish Deposits in the Stomach and Duodenum. [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue 10, Page 1913-1915, December 2025.
Yang KY, Zhou XJ, Xie W.
europepmc   +2 more sources

The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report. [PDF]

J Paediatr Child Health
Journal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1332-1337, August 2025.
Rodrigues F, Hofman PL, Quinlan C, Zacharin M.   +3 more
europepmc   +2 more sources

Repurposing of sevelamer as a novel antidote against aluminum phosphide poisoning: An in vivo evaluation

Heliyon, 2023
Aluminum phosphide (AlP) is widely used for protecting grains from pests. AlP releases toxic phosphine gas (PH3) while exposed to humidity. Poisoning with these tablets is dangerous and can cause death or serious injuries. Up to now, no definite antidote
Reza Heidari, Hamid Reza Mohammadi, Fazel Goudarzi, Fatemeh Farjadian   +3 more
doaj   +1 more source

Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis. [PDF]

Hemodial Int
Abstract Introduction Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease‐mineral and bone disorder has been linked to reduced lifespan and worsened quality of life.
Georgopoulos C, Duni A, Stamellou E, Kitsos A, Gouva C, Dounousi E.   +5 more
europepmc   +2 more sources

Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study

Kidney Diseases, 2022
Introduction: Previous studies suggested that sevelamer carbonate is well tolerated with a favorable efficacy and safety profile in both dialysis and nondialysis patients in Europe; however, the efficacy remains controversial, and few studies have ...
Wei Chen, Hua-Feng Liu, Qin-Kai Chen, Ming-Hui Zhao, Xiao-Nong Chen, Hong Liu, Jian-Xin Wan, Shao-Mei Li, Meng-Hua Chen, Chun Dai, Hong-Bin Shi, Jia-Li Wei, Hong-Wen Zhao, Li-Hua Wang, Gang Long, Wan-Hong Lu, Ying Tang, Jun-Wei Yang, Li-Ying Cao, Dong-Xing Tang, Yu-Qiong Yang, Xue-Qing Yu   +21 more
doaj   +1 more source

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification

Frontiers in Cardiovascular Medicine, 2021
Objective: Sevelamer hydrochloride is a phosphate binder used to treat hyperphosphatemia in chronic kidney disease (CKD) patients that can reduce valvular and vascular calcification. The aim of this study was to examine the effects of sevelamer treatment
Zhen Meng, Zhe Li, Erli Zhang, Li Zhang, Qingrong Liu, Yongjian Wu   +5 more
doaj   +1 more source

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

Microorganisms, 2020
Despite the use of various pharmacotherapeutic strategies, fibrosis due to nonalcoholic steatohepatitis (NASH) remains an unsatisfied clinical issue. We investigated the effect of sevelamer, a hydrophilic bile acid sequestrant, on hepatic fibrosis in a ...
Yuki Tsuji, Kosuke Kaji, Mitsuteru Kitade, Daisuke Kaya, Koh Kitagawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Hiroaki Takaya, Hideto Kawaratani, Tadashi Namisaki, Kei Moriya, Takemi Akahane, Hitoshi Yoshiji   +12 more
doaj   +1 more source

Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency. [PDF]

PLoS ONE, 2016
INTRODUCTION:Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes of bone in chronic renal insufficiency (CRI). Here we explored the effects of sevelamer-HCl treatment on bone strength and structure in experimental CRI ...
Jarkko Jokihaara, Ilkka H Pörsti, Harri Sievänen, Peeter Kööbi, Pekka Kannus, Onni Niemelä, Russell T Turner, Urszula T Iwaniec, Teppo L N Järvinen   +8 more
doaj   +1 more source

Comparison of sevelamer and calcium carbonate in prevention of hypomagnesemia in hemodialysis patients

International Journal of Preventive Medicine, 2021
Background: Chronic kidney disease (CKD) is a life-threatening disease with numerous complications. Hemodialysis (HD) patients are prone to magnesium deficiency due to malnutrition, which can cause cardiovascular complications and increase mortality. The
Elahe Jandaghi, Maliheh Yarmohammadi, Raheb Ghorbani, Tahereh Jalali, Ali Khadjeh Salehani, Peiman Mohammad Khani   +5 more
doaj   +1 more source

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial

Toxins, 2021
P-cresyl sulfate and indoxyl sulfate are strongly associated with cardiovascular events and all-cause mortality in chronic kidney disease (CKD). This randomized controlled trial was conducted to compare the effects between sevelamer and calcium carbonate
Kullaya Takkavatakarn, Pongpratch Puapatanakul, Jeerath Phannajit, Warumphon Sukkumme, Pajaree Chariyavilaskul, Patita Sitticharoenchai, Asada Leelahavanichkul, Pisut Katavetin, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong   +10 more
doaj   +1 more source